FDA flags Revitaderm and Tridergel antiseptic wound care gels in fresh recall alert

The FDA has flagged a nationwide recall of two antiseptic wound care gels made by Blaine Labs after testing found microbial contamination.

In a recall alert posted April 8, 2026, the agency said the products were Revitaderm and Tridergel wound care gels. The FDA said testing identified Lysinibacillus fusiformis in the products.

According to the notice, the affected gels were distributed to healthcare providers nationwide. The recall was not tied to retail or internet sales.

Blaine Labs said it had not received any adverse-event reports at the time of the notice. The company’s recall announcement was dated April 7, while the FDA posted the alert and listed it on its recalls page the following day.

The recall adds to a growing list of medicine and medical-product safety alerts that can affect clinics and other care settings. FDA recall notices typically advise providers to stop using affected products and follow the company’s instructions for return or disposal.

No additional lot expansion or new safety findings were included in the initial alert.